company background image
AZTA logo

Azenta NasdaqGS:AZTA Stock Report

Last Price

US$54.04

Market Cap

US$2.5b

7D

0.2%

1Y

-15.6%

Updated

06 Feb, 2025

Data

Company Financials +

Azenta, Inc.

NasdaqGS:AZTA Stock Report

Market Cap: US$2.5b

AZTA Stock Overview

Provides biological and chemical compound sample exploration and management solutions for the life sciences market in the United States, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. More details

AZTA fundamental analysis
Snowflake Score
Valuation1/6
Future Growth3/6
Past Performance0/6
Financial Health6/6
Dividends0/6

Rewards

Earnings are forecast to grow 124.73% per year

Risk Analysis

No risks detected for AZTA from our risk checks.

My Notes

Capture your thoughts, links and company narrative

Azenta, Inc. Competitors

10x Genomics

NasdaqGS:TXG

US$1.8b

Sotera Health

NasdaqGS:SHC

US$3.9b

Fortrea Holdings

NasdaqGS:FTRE

US$1.4b

BioLife Solutions

NasdaqCM:BLFS

US$1.2b

Price History & Performance

Summary of share price highs, lows and changes for Azenta
Historical stock prices
Current Share PriceUS$54.04
52 Week HighUS$67.77
52 Week LowUS$38.82
Beta1.47
1 Month Change4.08%
3 Month Change20.68%
1 Year Change-15.62%
3 Year Change-38.71%
5 Year Change27.06%
Change since IPO440.40%

Recent News & Updates

Azenta: Taking A Pass

Jan 27

At US$51.81, Is Azenta, Inc. (NASDAQ:AZTA) Worth Looking At Closely?

Jan 10
At US$51.81, Is Azenta, Inc. (NASDAQ:AZTA) Worth Looking At Closely?

A Look At The Intrinsic Value Of Azenta, Inc. (NASDAQ:AZTA)

Dec 20
A Look At The Intrinsic Value Of Azenta, Inc. (NASDAQ:AZTA)

Recent updates

Azenta: Taking A Pass

Jan 27

At US$51.81, Is Azenta, Inc. (NASDAQ:AZTA) Worth Looking At Closely?

Jan 10
At US$51.81, Is Azenta, Inc. (NASDAQ:AZTA) Worth Looking At Closely?

A Look At The Intrinsic Value Of Azenta, Inc. (NASDAQ:AZTA)

Dec 20
A Look At The Intrinsic Value Of Azenta, Inc. (NASDAQ:AZTA)

Analysts Have Just Cut Their Azenta, Inc. (NASDAQ:AZTA) Revenue Estimates By 14%

Nov 17
Analysts Have Just Cut Their Azenta, Inc. (NASDAQ:AZTA) Revenue Estimates By 14%

Shareholders Should Be Pleased With Azenta, Inc.'s (NASDAQ:AZTA) Price

Nov 14
Shareholders Should Be Pleased With Azenta, Inc.'s (NASDAQ:AZTA) Price

Azenta: Life Science Play Is Not Coming To Life

Sep 11

Azenta, Inc.'s (NASDAQ:AZTA) Shares May Have Run Too Fast Too Soon

Jul 19
Azenta, Inc.'s (NASDAQ:AZTA) Shares May Have Run Too Fast Too Soon

Should You Investigate Azenta, Inc. (NASDAQ:AZTA) At US$52.18?

Apr 27
Should You Investigate Azenta, Inc. (NASDAQ:AZTA) At US$52.18?

Shareholders Should Be Pleased With Azenta, Inc.'s (NASDAQ:AZTA) Price

Apr 05
Shareholders Should Be Pleased With Azenta, Inc.'s (NASDAQ:AZTA) Price

Subdued Growth No Barrier To Azenta, Inc.'s (NASDAQ:AZTA) Price

Dec 28
Subdued Growth No Barrier To Azenta, Inc.'s (NASDAQ:AZTA) Price

Is There An Opportunity With Azenta, Inc.'s (NASDAQ:AZTA) 31% Undervaluation?

Nov 07
Is There An Opportunity With Azenta, Inc.'s (NASDAQ:AZTA) 31% Undervaluation?

At US$50.66, Is It Time To Put Azenta, Inc. (NASDAQ:AZTA) On Your Watch List?

Sep 13
At US$50.66, Is It Time To Put Azenta, Inc. (NASDAQ:AZTA) On Your Watch List?

Estimating The Fair Value Of Azenta, Inc. (NASDAQ:AZTA)

Aug 09
Estimating The Fair Value Of Azenta, Inc. (NASDAQ:AZTA)

Is Azenta, Inc. (NASDAQ:AZTA) Potentially Undervalued?

Jun 01
Is Azenta, Inc. (NASDAQ:AZTA) Potentially Undervalued?

Revenue Downgrade: Here's What Analysts Forecast For Azenta, Inc. (NASDAQ:AZTA)

May 11
Revenue Downgrade: Here's What Analysts Forecast For Azenta, Inc. (NASDAQ:AZTA)

Is Azenta, Inc. (NASDAQ:AZTA) Worth US$42.5 Based On Its Intrinsic Value?

Mar 30
Is Azenta, Inc. (NASDAQ:AZTA) Worth US$42.5 Based On Its Intrinsic Value?

Shareholder Returns

AZTAUS Life SciencesUS Market
7D0.2%0.2%0.6%
1Y-15.6%-4.8%22.4%

Return vs Industry: AZTA underperformed the US Life Sciences industry which returned -4.8% over the past year.

Return vs Market: AZTA underperformed the US Market which returned 22.4% over the past year.

Price Volatility

Is AZTA's price volatile compared to industry and market?
AZTA volatility
AZTA Average Weekly Movement5.3%
Life Sciences Industry Average Movement8.5%
Market Average Movement6.4%
10% most volatile stocks in US Market18.8%
10% least volatile stocks in US Market3.2%

Stable Share Price: AZTA has not had significant price volatility in the past 3 months compared to the US market.

Volatility Over Time: AZTA's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19783,300John P. Marottawww.azenta.com

Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences market in the United States, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates through three reportable segments: Sample Management Solutions, Multiomics, and B Medical Systems. The Sample Management Solutions segment provides sample management products and solutions, including automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled rate thawing devices, as well as sample repository services.

Azenta, Inc. Fundamentals Summary

How do Azenta's earnings and revenue compare to its market cap?
AZTA fundamental statistics
Market capUS$2.46b
Earnings (TTM)-US$166.40m
Revenue (TTM)US$662.11m

3.7x

P/S Ratio

-14.8x

P/E Ratio

Is AZTA overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
AZTA income statement (TTM)
RevenueUS$662.11m
Cost of RevenueUS$387.86m
Gross ProfitUS$274.25m
Other ExpensesUS$440.65m
Earnings-US$166.40m

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-3.64
Gross Margin41.42%
Net Profit Margin-25.13%
Debt/Equity Ratio0%

How did AZTA perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/06 02:23
End of Day Share Price 2025/02/06 00:00
Earnings2024/12/31
Annual Earnings2024/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Azenta, Inc. is covered by 18 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Christopher MuseBarclays
Brett HodessBofA Global Research
Yuan ZhiB. Riley Securities, Inc.